DEPRESSING –
June 17, 2026 – Millions of Americans who take a popular antidepressant are being urged to check their medicine cabinets after a staggering number of bottles were recalled amid concerns over possible contamination. The recall affects both 30 mg and 60 mg capsules of duloxetine, a widely prescribed medication used to treat depression, anxiety, fibromyalgia, and certain types of chronic nerve pain.According to the National Library of Medicine, N-nitroso-duloxetine is a nitrosamine compound that is “suspected of causing cancer.” The compound belongs to a broader class of chemicals that have triggered a string of high-profile drug recalls.
Duloxetine is one of the most commonly prescribed antidepressants in the U.S., and is sold separately under the brand name Cymbalta.
The recall affects the generic duloxetine delayed-release capsules manufactured by Towa Pharmaceutical. Cymbalta, which is manufactured by Lilly, is not impacted.
